Atlas Trials

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy

Clinical trial NCT05847049 · COMPLETED

Trial details

NCT number
NCT05847049
Sponsor
Dar El Oyoun Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Central Serous Chorioretinopathy
Start date
2023-02-28
Primary completion
2023-03-25
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.